News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|October 31, 2012

Applications, enrollment at medical schools up

First-time applicants and first-time enrollment for US medical schools reached an all-time high this year.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA approves generic baloxavir marboxil for flu treatment, prophylaxis

ByBenjamin P. Saylor

June 18th 2026

Spinal muscular atrophy pharmacotherapy: Getting an earlier start | Image Credit: © Rochu_2008 - stock.adobe.com.

Spinal muscular atrophy pharmacotherapy: Getting an earlier start

ByLauren Prack, PharmD

June 18th 2026

FDA clears Capvaxive as supplemental PCV for at-risk children

ByBenjamin P. Saylor

June 18th 2026

Journal Club: Small renal stones can be managed conservatively

Journal Club: Small renal stones can be managed conservatively

ByMarian Freedman,Jon Matthew Farber, MD

June 18th 2026

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

ByBenjamin P. Saylor

June 17th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Acoustic resonance therapy shows promise for pediatric chronic rhinitis

FDA clears Capvaxive as supplemental PCV for at-risk children